SEARCH RESULT

Total Matching Records found : 394

The battle over Bt cotton -Shamnad Basheer

-The Hindu While Monsanto and Indian Seed Companies spar, more worrying is the confused lawmaking underpinning regulation of patents Genetically Modified Organisms (GMOs) breed controversy like no other. Little wonder then that Monsanto’s much-maligned Bt cotton has spawned the mother of all intellectual property (IP) disputes in India, involving at least 15 different proceedings in various courts, government agencies and tribunals at last count. Most proceedings appear to have come at the behest...

More »

Jerome Oberreit, Secretary General of Medecins Sans Frontieres (MSF) or Doctors without Borders, interviewed by A Rangarajan

-The Hindu MSF Secretary General Jerome Oberreit on the increasing threat to affordable health care worldwide. Médecins Sans Frontières (MSF) or Doctors without Borders, the international humanitarian medical aid organisation that is active in 69 countries, serves populations affected by epidemics, armed conflicts, natural calamities and manmade disasters. MSF has relied heavily on generic drugs, much of which has been sourced from India, to deliver health care to some of the most...

More »

Monsanto stops release of new Bt cotton tech -Jacob Koshy

-The Hindu New Delhi: Seed technology major Monsanto says it is suspending plans to introduce an upgraded version of its genetically modified cotton in India because of uncertainty in the “business and regulatory environment”. Activists say this is a “hypocritical” position. On July 6, Monsanto notified the Genetic Engineering Appraisal Committee, the regulatory authority for approval of biotechnology traits in India, that it was withdrawing its application for the commercial release of...

More »

A disaster in the making -A Rangarajan

-Frontline Medecins Sans Frontieres warns that the free or regional trade agreements that are being negotiated, which seek to strengthen current patent regimes, are a potential threat to the developing world’s access to life-saving drugs, which it sources mostly from India. WHEN NELSON MANDELA’S GOVERNMENT passed the Medicines and Related Substances Control Act in 1997 to make medicines more accessible to the poor, 39 big pharmaceutical companies filed law suits in...

More »

India’s forests valued at Rs 115 trillion, but tribals unlikely to get a share -Kumar Sambhav Shrivastava

-Hindustan Times New Delhi: India’s forests are worth as much as the combined market value of BSE-listed companies with a notional value of Rs 115 trillion but the money collected from diverting parts of this land for industries won’t go to communities that live in and are dependent on the jungles. The Union environment ministry accepted most recommendations of a 2013 expert panel that hiked the rates at which industrialists pay for...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close